China Animal Vaccine Industry Report, 2011-2012
  • Jun/2012
  • Hard Copy
  • USD $2,500
  • Pages:117
  • Single User License
    (PDF Unprintable)       
  • USD $2,400
  • Code: XJT015
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,700
  • Hard Copy + Single User License
  • USD $2,700
Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine market shows vigorous development. In 2011, the market size of animal vaccine in China hit RMB7.92 billion. Since 2004, foot-and-mouth disease, highly pathogenic avian influenza (HPAI), highly pathogenic porcine reproductive and respiratory syndrome (HP-PRRS), swine fever and peste des petits ruminants have been brought into the scope of compulsory immunization by the government, which promotes the animal vaccine market to grow 28.1% annually. It is expected that Chinese market size of animal vaccine will amount to RMB9.56 billion in 2012.

Market Size of Chinese Animal Vaccine, 2000-2011

Pig and poultry raising is the backbone of Chinese animal husbandry, and the swine and poultry vaccines occupy more than 80% of China’s animal vaccine market. In 2011, the total sales of animal vaccines produced by Chinese animal vaccine enterprises approximated RMB7.11 billion (excluding net import value), of which the sales of swine vaccine and poultry vaccine registered RMB3.51 billion and RMB3.01 billion respectively, making up 49.4% and 42.3% of the total sales separately.

Chinese animal vaccine industry features high degree of industry concentration. In 2011, among major Chinese animal vaccine manufacturers, China Animal Husbandry Industry Co., Ltd. ranked No. 1 for its revenue of RMB1.18 billion, accounting for 14.9% market share. Moreover, the companies with market share of over 5.0% also include Xinjiang Tecon Animal Husbandry Bio-technology Co., Ltd., Guangdong Dahuanong Animal Health Products Co., Ltd. and Jinyu Group. As the state strengthens the regulatory oversight and the consumer’s brand awareness is improving, the concentration degree of Chinese animal vaccine industry will be enhanced as well.

It is in the report that covers the followings:
20120114.gif The market size, market structure, competitive landscape and technology development direction of the global animal vaccine industry;

20120114.gif The market size, import & export, profit, entry barriers, competition pattern and entry of foreign capital of Chinese animal vaccine industry;

20120114.gif Policy environment, compulsory immunization tendering system, reform direction and its influence on downstream husbandry development;

20120114.gif The forecasts of Chinese animal vaccine industry, including overall market, swine vaccine, poultry vaccine, cattle & sheep vaccine and pet vaccine, etc.;

20120114.gif Production, operation, investment, M&A, clients and suppliers, animal vaccine business and development forecast of 11 major animal vaccine enterprises in China.
1. Overview of Animal Vaccine
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Status Quo of Animal Vaccine Industry
2.1 Global Market
2.1.1 Market Size
2.1.2 Market Structure
2.1.3 Competitive Landscape
2.1.4 New Epidemics and Products
2.2 Chinese Market
2.2.1 Market Size
2.2.2 Import and Export
2.2.3 Profit 
2.2.4 Entry Barriers
2.2.5 Competitive Landscape

3. Development Environment of Animal Vaccine Industry in China
3.1 Policy Environment
3.1.1 Major Policies
3.1.2 Tendering System for Compulsory Immunization Vaccine 
3.2 Social Environment
3.2.1 Rapid Development of Husbandry
3.2.2 Large-scale Husbandry Becomes a Trend
3.2.3 Frequent Outbreaks of Animal Epidemics

4. Development Forecast of Animal Vaccine Industry in China
4.1 Overall Forecast
4.2 Swine Vaccines
4.3 Poultry Vaccines
4.4 Cattle & Sheep Vaccines
4.5 Pet Vaccines

5. Key Enterprises
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Clients and Suppliers
5.1.6 Animal Vaccine Business
5.1.7 Forecast and Outlook
5.2 Jinyu Group
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D and Investment
5.2.6 Clients
5.2.7 Animal Vaccine Business
5.2.8 Forecast and Outlook
5.3 Tecon
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R& D and Investment 
5.3.6 Clients and Suppliers
5.3.7 Animal Vaccine Business
5.3.8 Forecast and Outlook
5.4 Tech-bank
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 R&D and Investment
5.4.6 Clients and Suppliers
5.4.7 Animal Vaccine Business
5.4.8 Forecast and Outlook
5.5 Shenghua Biok
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 Clients and Suppliers
5.5.6 Animal Vaccine Business
5.5.7 Forecast and Outlook
5.6 Huasun Group
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Clients and Suppliers
5.6.6 Animal Vaccine Business
5.6.7 Forecast and Outlook
5.7 Harbin Pharmaceutical Group
5.7.1 Profile
5.7.2 Animal Vaccine Business
5.8 Ringpu Bio-technology
5.8.1 Profile
5.8.2 Operation
5.8.3 Revenue Structure
5.8.4 Gross Margin
5.8.5 R&D and Investment
5.8.6 Clients and Suppliers
5.8.7 Animal Vaccine Business
5.8.8 Forecast and Outlook
5.9 Dahuanong
5.9.1 Profile
5.9.2 Operation
5.9.3 Revenue Structure
5.9.4 Gross Margin
5.9.5 R&D and Investment
5.9.6 Clients and Suppliers
5.9.7 Animal Vaccine Business
5.9.8 Forecast and Outlook
5.10 Yikang
5.10.1 Profile
5.10.2 Operation
5.10.3 Revenue Structure
5.10.4 Gross Margin
5.10.5 R&D and Investment
5.10.6 Clients and Suppliers
5.10.7 Animal Vaccine Business
5.11 Chopper
5.11.1 Profile
5.11.2 Operation
5.11.3 Revenue Structure
5.11.4 Gross Margin
5.11.5 R&D and Investment
5.11.6 Clients and Suppliers
5.11.7 Animal Vaccine Business
Classification of Animal Health Products
Animal Vaccine Types (by Constituent and Feature) and Characteristics
Animal Vaccine Industry Chain
Classification of Animal Epidemics in China
Sales of Global Animal Vaccine, 2008-2014E
Profile of Global Animal Health Products Giants
Revenue of Animal Vaccine Business of Global Major Animal Health Products Enterprises, 2010
Revenue Structure of Global Major Animal Health Products Enterprises (by Product), 2010
Commercialized Vaccines and Manufacturers in Overseas Market in Recent Years
Market Size of Chinese Animal Vaccine, 2000-2011
Market Structure of Chinese Animal Vaccine (by Animal Species), 2008-2011
Export Volume and Export Value of Chinese Animal Vaccine, 2007-2011
Oversea Market Distribution of Chinese Animal Vaccine, 2011
Average Export Prices of China’s Animal Vaccine, 2007-2011
Import Volume and Import Value of Chinese Animal Vaccine, 2007-2011
Origins of China’s Imported Animal Vaccines, 2011
Average Import Prices of Animal Vaccine in China, 2007-2011
Gross Margin of Animal Vaccine Enterprises of Different Scale in China, 2010
Gross Margin of Animal Vaccine Business of Major Listed Animal Vaccine Companies in China, 2011
Barriers to Entry into Animal Vaccine Industry in China
Revenue of Animal Vaccine Enterprises (by Company Type) in China, 2010
Revenue of Animal Vaccine Business of Major Listed Animal Vaccine Companies in China, 2011
Production of China’s Key Animal Vaccine Manufacturers
Industry Concentration of Animal Vaccine Industry(by Animal Species) in China, 2011
Gap between Chinese Vaccine Production Process and International Advanced Level
Sino-foreign Joint Animal Vaccine Enterprises, 1990-2011
Major Polices on Animal Vaccine Industry in China, 2010-Apr. 2012
Compulsory Immunization Plan of Animal Epidemics in China, 2011
Prices of Governmental Tender Vaccine, 2009 and 2011
Defect of Compulsory Vaccination Tender System in China
Reform Direction of Compulsory Vaccination Tender System in China
Output of Meat, Eggs and Milk in China, 2007-2011
Per-capita Consumption of Meat in China, 1990-2020E
Meat Consumption Structure of Urban Residents in China, 1990-2010
Meat Consumption Structure of Rural Residents in China, 1990-2010
Meat Consumption Structure of Chinese Residents, 2020E
Market Capacity of Meat in China, 2020E
Proportion of Epidemic Prevention Expense in the Cost of Pig Breeding in China, 2005-2010
Breeding Scale Degree in China, 2010-2020E
Epidemic Prevention Costs of Pig Breeding in China, 2005-2010 
Epidemic Prevention Cost per One Hundred Broilers and Layers in China, 2010
Overview of Common Animal Epidemic Situation in China
Major Animal Epidemics Reported by China to OIE, 2007-2012
Market Size of Chinese Animal Vaccine, 2007-2012
Market Structure of Chinese Animal Vaccine (by Animal Species), 2010-2012
Pig Breeding Stock and Slaughter Quantity in China, 2000-2011
Sales of Swine Vaccine of Animal Vaccine Enterprises in China, 2008-2012
Market Competition of PCV Vaccine in China, 2011
Sales of Poultry Vaccine of Animal Vaccine Enterprises in China, 2008-2012
Sales of Cattle & Sheep Vaccine of Animal Vaccine Enterprises in China, 2008-2012
Provincial Per Capita GDP in China, 2011
Birth Rate in China, 1952-2011
Sales of Pet Vaccine Enterprises in China, 2008-2012
Pet Vaccine Suppliers in Chinese Market
Revenue and Net Income of CAHIC, 2008-2011
Revenue of CAHIC by Product, 2008-2011
Revenue of CAHIC by Region, 2008-2011
Gross Margin of Main Products of CAHIC, 2008-2011
CAHIC’s Sales from Top 5 Clients and % of Total Revenue, 2008-2011
CAHIC’s Procurement from Top 5 Suppliers and % of Total Procurement, 2008-2011
Sales Volume of CAHIC Animal Vaccines, 2007-2011
Animal Vaccine Capacity Distribution of CAHIC
Revenue and Net Income of CAHIC, 2011-2013E
Revenue and Net Income of Jinyu Group, 2008-2011
Revenue of Jinyu Group by Product, 2008-2011
Revenue of Jinyu Group by Region, 2008-2011
Gross Margin of Main Products of Jinyu Group, 2008-2011
R&D Costs and % of Total Revenue of Jinyu Group, 2009-2011
Jinyu Group’s Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Animal Vaccine Capacity Distribution of Jinyu Group
Revenue and Gross Margin of Biological Products Business of Jinyu Group, 2008-2011
Revenue and Net Income of Jinyu Group, 2011-2013E
Revenue and Net Income of Tecon, 2008-2011
Revenue of Tecon by Product, 2008-2011
Revenue of Tecon by Region, 2008-2011
Gross Margin of Main Products of Tecon, 2008-2011
R&D Costs and % of Total Revenue of Tecon, 2008-2011
Tecon’s Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Name list and Revenue Contribution of Tecon’s Top 5 Clients, 2011
Name list, procurement and % of Tecon’s Top 5 Suppliers, 2011
Revenue and Gross Margin of Tecon’s Animal Vaccine Business, 2007-2011
Animal Vaccine R & D Projects and Progress of Tecon, by the End of 2011
Animal Vaccine Investment Projects of Tecon, 2011
Revenue and Net Income of Tecon, 2011-2013E
Revenue and Net Income of Tech-bank, 2008-2011
Revenue of Tech-bank by Product, 2008-2011
Revenue of Tech-bank by Region, 2008-2011
Gross Margin of Major Products of Tech-bank, 2008-2011
R&D Costs and % of Total Revenue of Tech-bank, 2008-2011
Tech-bank’s Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Tech-bank’s Procurement from Top 5 Suppliers and % of Total Procurement, 2008-2012
Revenue and Gross Margin of Tech-bank’s Biological Products Business, 2008-2012
Revenue and Net Income of Tech-bank, 2011-2013E
Revenue and Net Income of Shenghua Biok, 2008-2011
Revenue of Shenghua Biok by Product, 2008-2011
Revenue of Shenghua Biok by Region, 2008-2011
Gross Margin of Main Products of Shenghua Biok, 2008-2011
Shenghua Biok’s Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Shenghua Biok’s Procurement from Top 5 Suppliers and % of Total Procurement, 2008-2012
Revenue and Net Income of Qingdao Yebio, 2008-2011
Revenue and Net Income of Shenghua Biok, 2011-2013E
Revenue and Net Income of Huasun Group, 2008-2011
Revenue of Huasun Group by Product, 2008-2011
Revenue of Huasun Group by Region, 2008-2011
Gross Margin of Main Products of Huasun Group, 2008-2011
Huasun Group’s Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Huasun Group’s Procurement from Top 5 Suppliers and % of Total Procurement, 2008-2011
Revenue of Huasun Animal Bioproducts Co., Ltd., 2008-2011
Revenue and Net Income of Huasun Group, 2011-2013E
Revenue and Net Income of Ringpu, 2008-2011
Revenue of Ringpu by Product, 2008-2011
Revenue of Ringpu by Region, 2008-2011
Gross Margin of Main Products of Ringpu, 2008-2011
R&D Costs and % of Total Revenue of Ringpu, 2008-2012
Ringpu’s Sales from Top 5 Clients and % of Total Revenue, 2008-2012
Ringpu’s Procurement from Top 5 Suppliers and % of Total Procurement, 2008-2012
Ringpu’s Animal Vaccine Subsidiaries and Their Net Income, 2011
Production of Newly-added Capacity of Ringpu, 2012
Sales of Market-oriented Vaccines and Its Proportion in Ringpu’s Revenue, 2009-2011
Revenue and Net Income of Ringpu, 2011-2013E
Revenue and Net Income of Dahuanong, 2008-2011
Revenue of Dahuanong by Product, 2008-2011
Revenue of Dahuanong by Region, 2008-2011
Gross Margin of Major Products of Dahuanong, 2008-2011
R&D Costs and % of Total Revenue of Dahuanong, 2008-2011
Dahuanong’s Sales from Top 5 Clients and % of Total Revenue, 2008-2011
Revenue and Gross Margin of Dahuanong’s Animal Vaccine Business, 2008-2011
Revenue and Net Income of Dahuanong, 2011-2013E
Revenue and Net Income of Yikang, 2009-2011
Revenue of Yikang by Product, 2009-2011
Revenue of Yikang by Region, 2009-2011
Gross Margin of Main Products of Yikang, 2009-2011
R&D Costs and % of Total Revenue of Yikang, 2009-2012
Yikang’s Sales from Top 5 Clients and % of Total Revenue, 2009-2011
Name list and Revenue Contribution of Yikang’s Top 5 Clients, 2011
Yikang’s Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
Name list, procurement and % of Yikang’s Top 5 Suppliers, 2011
Animal Vaccine Production Lines of Yikang, 2009-2011
Capacity, Output and Capacity Utilization of Yikang, 2009-2011
Output, Sales Volume and Sales-output Ratio of Yikang, 2009-2011
Average Sale Prices of Yikang’s Major Products, 2009-2011
Revenue of Yikang by Sales Model, 2009-2011
Revenue and Net Income of Chopper, 2009-2011
Revenue of Chopper by Product, 2009-2011
Revenue of Chopper by Region, 2009-2011
Gross Margin of Main Products of Chopper, 2009-2011
R&D Costs and % of Total Revenue of Chopper, 2009-2011
Chopper’s Sales from Top 5 Clients and % of Total Revenue, 2009-2011
Name list and Revenue Contribution of Chopper’s Top 5 Clients, 2011
Sales Contracts of Chopper and Animal Husbandry and Veterinary Bureau of Hubei Province, 2011
Chopper’s Procurement from Top 5 Suppliers and % of Total Procurement,2009-2011
Name list, procurement and % of Chopper’s Top 5 Suppliers, 2011
Capacity, Output and Capacity Utilization of Chopper, 2009-2011
Output, Sales Volume and Sales-output Ratio of Chopper, 2009-2011
Average Sale Prices of Chopper’s Major Products, 2009-2011
Investment Plan of Chopper, 2012

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Contract Research Organization (CRO) Industry Report, 2020-2026

The contract research organization (CRO) industry has been galloping amid the global pharmaceutical market steadily in head way, the vibrant financing in the medical and health sector, and the prolife...

China Human Vaccine Industry Report, 2020-2026

In China, the lot release for human vaccines plunged by 17.7% in 2018 when the production record fraud of rabies vaccines for human use, freeze-dried by Changsheng Bio-Technology was exposed. The impa...

China Pharmaceutical Distribution Industry Report, 2019-2026

The Chinese pharmaceutical distribution market has been expanding steadily over the recent years, being valued at RMB2,330.3 billion in 2019 with a year-on-year increase of 8.9%, of which the pharmace...

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号